Brenda Finucane is associate director of the Autism and Developmental Medicine Institute at Geisinger in Lewisburg, Pennsylvania.
Brenda Finucane
Associate director
Autism and Developmental Medicine Institute at Geisinger
From this contributor
Q&A with Brenda Finucane: Building pipelines for genetic tests for autism
Most autistic people do not receive the medically recommended genetic tests for autism. Brenda Finucane and her colleagues want to change that.
Q&A with Brenda Finucane: Building pipelines for genetic tests for autism
By
Angie Voyles Askham
17 August 2021 | 6 min read
Explore more from The Transmitter
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
By
Sarah Thau
24 July 2026 | 4 min read
In memoriam: Kevin Dunbar, who traced the neural basis of human reasoning
Using imaging technologies, he transformed our understanding of how creativity and scientific discovery arise in the brain.
In memoriam: Kevin Dunbar, who traced the neural basis of human reasoning
Using imaging technologies, he transformed our understanding of how creativity and scientific discovery arise in the brain.
By
Alissa de Chassey
24 July 2026 | 6 min read
Neurons engage in risky, DNA-breaking business during migration
The cells later repair the damage, which occurs mostly in transcriptionally silent parts of the genome.
Neurons engage in risky, DNA-breaking business during migration
The cells later repair the damage, which occurs mostly in transcriptionally silent parts of the genome.
By
Sarah Thau
24 July 2026 | 4 min read